Explore the words cloud of the TB and Tobacco project. It provides you a very rough idea of what is the project "TB and Tobacco" about.
The following table provides information about the project.
UNIVERSITY OF YORK
|Coordinator Country||United Kingdom [UK]|
|Total cost||2˙999˙828 €|
|EC max contribution||2˙999˙828 € (100%)|
1. H2020-EU.3.1.3. (Treating and managing disease)
|Duration (year-month-day)||from 2015-11-01 to 2019-10-31|
Take a look of project's partnership.
|1||UNIVERSITY OF YORK||UK (YORK NORTH YORKSHIRE)||coordinator||1˙085˙001.00|
|2||ARK FOUNDATION||BD (DHAKA)||participant||477˙773.00|
|3||THE INITIATIVE||PK (Islamabad)||participant||430˙743.00|
|4||UNIVERSITY OF LEEDS||UK (LEEDS)||participant||357˙205.00|
|5||HEINRICH-HEINE-UNIVERSITAET DUESSELDORF||DE (DUSSELDORF)||participant||209˙845.00|
|6||VSEOBECNA FAKULTNI NEMOCNICE V PRAZE||CZ (PRAHA 2)||participant||140˙141.00|
|7||HERD INTERNATIONAL PVT LTD||NP (KATHMANDU)||participant||125˙097.00|
|8||MINISTRY OF NATIONAL HEALTH SERICES, REGULATION AND COORDINATION||PK (ISLAMABAD)||participant||113˙925.00|
|9||THE UNIVERSITY OF EDINBURGH||UK (EDINBURGH)||participant||60˙096.00|
|10||HEALTH RESEARCH AND SOCIAL DEVELOPMENT FORUM||NP (KATHMANDU)||participant||0.00|
We aim to reduce the burden of tobacco-related lung diseases. Our approach is to integrate inexpensive tobacco cessation strategies of proven efficacy into TB control programmes. This has three advantages: a) Preventing non-communicable diseases as well as reducing TB-related deaths; b) TB patients are more likely to quit tobacco than healthy smokers – ‘teachable moments’; and c) in the absence of specialist infrastructure, an approach to ‘piggyback’ cessation on existing programmes is a desirable policy imperative. We will first assess the effectiveness and cost-effectiveness of tobacco cessation strategies in helping TB patients to quit and improving their TB outcomes - the effectiveness goal; and then explore how best these strategies can be delivered, sustained and scaled-up – the implementation goal. We propose six work packages for Bangladesh, Nepal and Pakistan - high TB and tobacco burden countries. WP1 Development & Feasibility: To optimise the delivery of tobacco cessation strategies within TB programmes (focus group discussions [FGD], interviews, surveys, expert panel workshops) WP2 & 3 Effect and economic evaluation: To assess the effectiveness and cost effectiveness of cytisine with behavioural support vs. behavioural support alone on tobacco cessation and TB outcomes (randomised controlled trial [RCT]) WP4 Process evaluation: To study the design and delivery of the tobacco cessation strategies (FGD, observations, exit interviews) WP5 Context evaluation: To study the influence of contextual factors on the RCT outcomes (lit. review, interviews, surveys, analysis) WP6 Scale up & Sustainability: To assess sustainability of the cessation strategies and identify the likely costs, obstacles and opportunities for scaling these up (FGD, interviews, cost and outcomes analysis) Our ambition is that by studying the ‘real world’ influences on the implementation and success of tobacco cessation we will be able to translate our findings into benefits for patients
|Trial Register - results||Websites, patent fillings, videos etc.||2020-02-12 16:49:05|
|Report on the trial||Documents, reports||2020-02-12 16:49:02|
|Scaling up budget||Documents, reports||2020-02-12 16:49:02|
|Process eval report - SC||Documents, reports||2020-02-12 16:49:05|
|Process eval report -SH||Documents, reports||2020-02-12 16:49:05|
|Economic Analysis Report||Documents, reports||2020-02-12 16:49:05|
|Tobacco use scales||Documents, reports||2020-02-12 16:49:03|
|\'Way Forward\' report||Documents, reports||2020-02-12 16:49:02|
|Interventions and Lessons||Documents, reports||2020-02-12 16:48:58|
|Outcome factors report||Documents, reports||2020-02-12 16:49:00|
|Delivery factors report||Documents, reports||2020-01-27 09:00:45|
|All approvals package||Documents, reports||2020-01-27 09:00:45|
|Intervention materials||Demonstrators, pilots, prototypes||2020-01-27 09:00:45|
|Project website||Websites, patent fillings, videos etc.||2020-01-27 09:00:45|
Take a look to the deliverables list in detail: detailed list of TB and Tobacco deliverables.
|year||authors and title||journal||last update|
Constantine I. Vardavas, Christina N. Kyriakos, Esteve FernÃ¡ndez, Panagiotis Bamidis, Kamran Siddiqi, Niels H. Chavannes, R.M.J.J. van der Kleij, Gary Parker, Cornel Radu-Loghin, Brian Ward, Karim Berkouk
H2020 funding for respiratory research: scaling up for the prevention and treatment of lung diseases
published pages: 1901417, ISSN: 0903-1936, DOI: 10.1183/13993003.01417-2019
|European Respiratory Journal 54/3||2020-01-28|
Melanie Boeckmann, Iveta Nohavova, Omara Dogar, Eva Kralikova, Alexandra Pankova, Kamila Zvolska, Rumana Huque, Razia Fatima, Maryam Noor, Helen Elsey, Aziz Sheikh, Kamran Siddiqi, Daniel Kotz
Protocol for the mixed-methods process and context evaluation of the TB & Tobacco randomised controlled trial in Bangladesh and Pakistan: a hybrid effectivenessâ€“implementation study
published pages: e019878, ISSN: 2044-6055, DOI: 10.1136/bmjopen-2017-019878
|BMJ Open 8/3||2020-01-28|
Sahil Warsi, Helen Elsey, Melanie Boeckmann, Maryam Noor, Amina Khan, Deepa Barua, Shammi Nasreen, Samina Huque, Rumana Huque, Sudeepa Khanal, Prabin Shrestha, James Newell, Omara Dogar, Kamran Siddiqi
Using behaviour change theory to train health workers on tobacco cessation support for tuberculosis patients: a mixed-methods study in Bangladesh, Nepal and Pakistan
published pages: , ISSN: 1472-6963, DOI: 10.1186/s12913-019-3909-4
|BMC Health Services Research 19/1||2020-01-28|
Dogar, Omara Fatima; Barua, Deepa; Boeckmann, Melanie; Elsey, Helen; Fatima, Razia; Gabe, Rhian; Huque, Rumana; Keding, Ada; Khan, Amina; Kotz, Daniel; Kralikova, Eva; Newell, James N; Nohavova, Iveta; Parrott, Steven James; Readshaw, Anne Elizabeth; Renwick, Charlotte; Sheikh, Aziz; Siddiqi, Kamran
The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patientsprotocol for a double-blind, placebo-controlled randomized trial
published pages: , ISSN: 0965-2140, DOI: 10.1111/add.14242
Omara Dogar, Jan R. Boehnke, Fabiana Lorencatto, Trevor A. Sheldon, Kamran Siddiqi
Measuring fidelity to behavioural support delivery for smoking cessation and its association with outcomes
published pages: , ISSN: 0965-2140, DOI: 10.1111/add.14804
Melanie Boeckmann, Sahil Warsi, Maryam Noor, Omara Dogar, Esha Haowa Mustagfira, Fariza Firoze, Raana Zahid, Anne Readshaw, Kamran Siddiqi, Daniel Kotz
Health worker and patient views on implementation of smoking cessation in routine tuberculosis care
published pages: , ISSN: 2055-1010, DOI: 10.1038/s41533-019-0146-6
|npj Primary Care Respiratory Medicine 29/1||2020-01-28|
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TB AND TOBACCO" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "TB AND TOBACCO" are provided by the European Opendata Portal: CORDIS opendata.
PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregiversRead More
CeLac and European consortium for a personalized medicine approach to Gastric CancerRead More
Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired PneumoniaRead More